Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ifyouSEQelaine
    Junior Member
    • Apr 2019
    • 1

    #1

    FastQC interpretation

    Hello,

    I would love some advice on my linked image below. I was using FastQC to look at the data from a recent MiSeq run. All my isolates are flagged at the "Per base sequence content". I am to understand that a 'good' graph is expected to look like all the bases are of similar % throughout. The DNA sequenced is from Pseudomonas aeruginosa, and I am seeing a high GC content (as expected) and much lower AT content.

    Any advice or explanation would be greatly helpful!

    Click image for larger version

Name:	Capture.PNG
Views:	1
Size:	83.8 KB
ID:	309592
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    This type of pattern is observed in a couple of cases. One is random priming used in RNAseq libraries and other is where you are making libraries that include transposases. The bias at the beginning of the reads is likely due to the Nextera transposase sequence bias (similar to bias seen in "random priming") .
    Last edited by GenoMax; 04-25-2019, 07:47 AM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:35 AM
    0 responses
    7 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    25 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...